Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,435.77 +54.42 (+0.65%) Bitcoin USD
62,564.03 +1,173.39 (+1.91%) CMC Crypto 200
1,304.27 -53.74 (-3.96%)
Fresenius SE & Co. KGaA (FRE.DE)
| Previous close | 28.03 |
| Open | 28.24 |
| Bid | 28.73 x N/A |
| Ask | 28.75 x N/A |
| Day's range | 28.24 - 28.81 |
| 52-week range | 23.93 - 31.22 |
| Volume | |
| Avg. volume | 1,154,182 |
| Market cap | 16.176B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 45.59 |
| EPS (TTM) | 0.63 |
| Earnings date | 31 Jul 2024 |
| Forward dividend & yield | 0.92 (3.19%) |
| Ex-dividend date | 18 May 2023 |
| 1y target est | 35.30 |
- Reuters
UPDATE 2-Fresenius raises outlook on strong quarterly results, exits Vamed
German healthcare group Fresenius first-quarter results beat expectations, the company said on Wednesday, citing strong performance at its Kabi and Helios businesses, prompting it to raise its full-year outlook. First-quarter earnings before interest and tax (EBIT) were 633 million euros ($680 million), above analysts' expectations of 606 million euros, according to a consensus of forecasts from Vara Research. In a bid to get leaner, Fresenius also said that it would sell its investment unit, Fresenius Vamed, completing its portfolio restructuring.
Simply Wall St.Institutions own 30% of Fresenius SE & Co. KGaA (ETR:FRE) shares but retail investors control 43% of the company
Key Insights Fresenius SE KGaA's significant retail investors ownership suggests that the key decisions are influenced...
- Simply Wall St.
Is Now The Time To Look At Buying Fresenius SE & Co. KGaA (ETR:FRE)?
Today we're going to take a look at the well-established Fresenius SE & Co. KGaA ( ETR:FRE ). The company's stock saw...
